# VALGANCICLOVIR HYDROCHLORIDE
> **ANDA215124** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2022-11-17
## Drug
- **FDA Application Number:** ANDA215124
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VALGANCICLOVIR HYDROCHLORIDE
- **Generic name:** VALGANCICLOVIR HYDROCHLORIDE POWDER,
- **Active ingredients:** VALGANCICLOVIR HYDROCHLORIDE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2022-11-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215124)
---
*AI Analytics · CC0 1.0*